Thymoma - Incidence, classification and therapy;Thymome - Inzidenz, klassifikation und therapie

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 40, 2007, Pages 2090-2095

  Stremmel, Christian ^a,b   Dango, S ^a   Thiemann, U ^a   Kayser, G ^a   Passlick, B ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Classification; Prognostic factor; Therapy; Thymoma; Thymuscarcinoma

Indexed keywords

CISPLATIN; IMATINIB; OCTREOTIDE; PREDNISOLONE;

ADJUVANT CHEMOTHERAPY; CANCER SURGERY; COMBINATION CHEMOTHERAPY; DISEASE CLASSIFICATION; GOLD STANDARD; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MORBIDITY; MYASTHENIA GRAVIS; PATIENT CARE; REVIEW; THYMOMA; TUMOR BIOPSY; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION; ADJUVANT THERAPY; CANCER STAGING; CLASSIFICATION; LYMPHADENECTOMY; MORTALITY; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

CHEMOTHERAPY, ADJUVANT; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; THYMOMA; THYMUS NEOPLASMS;

EID: 34848894226     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985647     Document Type: Review

References (48)

1. Akaogi E, Ohara K, Mitsui K et al. Preoperative radiotherapy and surgery for advanced thymoma with invasion of the great vessels. J Surg Oncol 1996; 63 (1): 17-22
2. Attanoos RL, Galateau-Salle F, Gibbs AR, Muller S, Ghandour F, Dojcinov SD. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma. Histopathology 2002; 41 (1): 42-9
3. Bergh NP, Glatzinsky P, Larsson S, Lundin P, Ridell B. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg 1978; 25: 91-8
4. Blumberg D, Port JL, Weksler B et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995; 60 (4): 908-13; discussion 914
5. Chalabreysse L, Etienne-Mastroianni B, Adeleine P, Cordier JF, Greenland T, Thivolet-Bejui F. Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology 2004; 44 (4): 367-74
6. Chalabreysse L, Roy P, Cordier JF, Loire R, Gamondes JP, Thivolet-Bejui F. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 2002; 26 (12): 1605-11
7. Cowen D, Richaud P, Mornex F et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Radiother Oncol 1995; 34 (1): 9-16
8. Crucitti F, Doglietto GB, Bellantone R, Perri V, Tommasini O, Tonali P. Effects of surgical treatment in thymoma with myasthenia gravis: our experience in 103 patients. J Surg Oncol 1992; 50 (1): 43-6
9. Curran WJJr, Kornstein MJ, Brooks JJ, Turrisi AT3rd . Invasive thymoma: the role of mediastinal irradiation follwing complete or incomplete surgical resection. J Clin Oncol 1988; 6 (11): 1722-7
10. Dadmanesh F, Sekihara T, Rosai J. Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am 2001; 11 (2): 407-20
11. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006; 81 (6): 2328-34
12. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004; 77 (5): 1860-9
13. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003; 105 (4): 546-51
14. Fukai I, Masoaka A, Fujii Y et al. Thymic neuroendocrine tumors (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 1999; 67: 208-11
15. Gal AA, Kornstein MJ, Cohen C, Duarte IG, Miller JI, Mansour KA. Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study. Ann Thorac Surg 2001; 72 (4): 1179-82
16. Giaccone G. Treatment of thymoma and thymic carcinoma. Ann Oncol 2000; 11, Suppl 3: 245-6
17. Giaccone G. Treatment of malignant thymoma. Curr Opin Oncol 2005; 17 (2): 140-6
18. Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N. Cisplatin and etoposide combination chemotherapy for locally advanced or metastsatic thymoma. J Clin Oncol 1996; 14 (3): 814-20
19. Greene MA, Malias MA. Aggressive multimodality treatment of invasive thymic carcinoma. J Thorac Cardiovasc Surg 2003; 125 (2): 434-6
20. Kim DJ, Yang WI, Choi SS, Kim KD et al. Prognostic and clinical relevance of the world health organisation schema for classification of thymic epithelial tumors. Chest 2005; 127: 755-61
21. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003; 76 (3): 878-84; discussion 884-5
22. Kondo K, Monden Y. Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 2003; 76: 1859-65
23. Lardinois D, Rechsteiner R, Lang RH et al. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000; 69 (5): 1550-5
24. Lastoria S, Vergara E, Palmieri G et al. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med 1998; 39 (4): 634-9
25. Levine GD, Rosai J. Thymic hyperplasia and neoplasia: A review of current concepts. Hum Pathol 1978; 9: 495-515
26. Loehrer P, Wei W, Johnsosn D et al. Octreotid alone or withPrednisone in patients with advanced thymoma and thymic carcinoma: an eastern kooperative oncology group phase II trial. JCO 2004; 22 (2): 293-99
27. Lopez-Cano M, Ponseti-Bosch JM, Espin-Basany E, Sanchez-Garcia JL, Armengol-Carrasco M. Clinical and pathological redictors of outcome in thymoma-associated myasthenia gravis. Ann Thorac Surg 2003; 76: 1643-9
28. Macchiarini P, Chella A, Ducci F et al. Neoadjuvant chemotherapy, surgery, and radiation therapy for invasive thymoma. Cancer 1991; 68 (4): 706-13
29. Masaoka A, Monden Y, Nakahana K, Tanioka T. Follow-up study of thymomas with special references to their clinical stages. Cancer 1981; 48: 2485-2492
30. Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991; 51 (1): 152-6
31. Maggi G, Giaccone G, Donadio M et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer 1986; 58 (3): 765-76
32. Monden Y, Nakahara K, Iioka S et al. Recurrence of thymoma: clinicopathological features, therapy and prognosis. Ann Thorac Surg 1985; 39: 165-9
33. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000; 114: 100-10
34. Nakahara K, Ohno K, Hashimoto J et al. Thymoma. Results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 1988; 95: 1041-7
35. Okumura M, Shinichiro M, Fujii Y et al. Clinical and functional significance of WHO classification on Human Thymic Epithelial Neoplasms. Am J Surg Pathol 2002; 25 (1): 103-110
36. Palmieri G, Montella L, Martignetti A et al. Somatostatin analoges and prednisone in advanced refractory thymic tumors. Cancer 2002; 94: 1414-20
37. Pich A, Chiarle R, Chiusa L et al. Long-term survival of thymoma patients by histologic pattern and proliferative activity. Am J Surg Pathol 1995; 19 (8): 918-926
38. Rea F, Marulli G, Girardi R et al. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 2004; 26 (2): 412-8
39. Rea F, Sartori F, Loy M et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993; 106 (3): 543-9
40. Regnard J-F, Magdeleinat P, Dromer C et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996; 112: 376-84
41. Ribet M, Voisin C, Pruvot FR, Ramon P, Dambron P. Lympho-epithelial thymomas. A retrospective study of 88 resections. Eur J Cardiovasc Surg 1988; 2 (4): 261-4
42. Rieker RJ, Hoegel J, Morresi-Hauf A et al. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 2002; 98 (6): 900-6
43. Strobel P, Hartmann M, Jakob A et al. thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med 2004; 350 (25): 2625-6
44. Strobel P, Marx A, Zettl A, Mueller-Hermelink HK. Thymoma and thymic carcinoma: An update of the WHO classification 2004. Surg Today 2005; 35 (10): 805-11
45. Urgesi A, Monetti U, Rossi G, Ricardi U, Casadio C. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 1990; 19 (3): 273-80
46. Venuta F, Rendina EA, Longo F et al. Long-term outcome after multi-modality treatment for stage III thymic tumors. Ann Thorac Surg 2003; 76 (6): 1866-72; discussion 1872
47. Yamakawa Y, Masaoka A, Hashimoto T et al. A tentative tumor-node.metastaseis classification of thymoma. Cancer 1991; 68 (9): 1984-7
48. Yim AP. VATS Major pulmonary resection revisited - controversies, techniques, and results. Ann Thorac Surg 2002; 74: 615-23